Speakers & Program

Program

The 2026 CIMT Annual Meeting will feature the latest breakthroughs in translational cancer immunotherapy research, with a program that will span innovative therapies, advances for precise patient selection, and in-depth insights into immune-cancer interactions. Sessions will include focused discussions on Improving Immunity, Tumor Microenvironment, Novel Targets, Cellular Therapies, etc.  

2026 Confirmed Speakers

Lunch and Learn Speaker:

No items found.

Subscribe to the CIMT newsletter

Stay up to date on Europe’s largest meeting focused on cancer immunotherapy research and development